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Abstract
An association between maternal smoking in pregnancy and autism may be biologically plausible, but the evidence to
date is inconsistent. We aimed to investigate the causal relationship between maternal smoking during pregnancy and
offspring autism using conventional analysis and causal inference methods. In the Avon Longitudinal Study of Parents
and Children we investigated the association of maternal smoking during pregnancy (exposure) with offspring autism
spectrum disorder (ASD) or possible ASD diagnosis (n= 11,946) and high scores on four autism-related traits
(outcomes) (n= 7402–9152). Maternal smoking was self-reported and also measured using an epigenetic score (n=
866–964). Partner’s smoking was used as a negative control for intrauterine exposure (n= 6616–10,995). Mendelian
randomisation (n= 1002–2037) was carried out using a genetic variant at the CHRNA3 locus in maternal DNA as a
proxy for heaviness of smoking. In observational analysis, we observed an association between smoking during
pregnancy and impairments in social communication [OR= 1.56, 95% CI= 1.29, 1.87] and repetitive behaviours, but
multivariable adjustment suggested evidence for confounding. There was weaker evidence of such association for the
other traits or a diagnosis of autism. The magnitude of association for partner’s smoking with impairments in social
communication was similar [OR= 1.56, 95% CI= 1.30, 1.87] suggesting potential for shared confounding. There was
weak evidence for an association of the epigenetic score or genetic variation at CHRNA3 with ASD or any of the
autism-related traits. In conclusion, using several analytic methods, we did not ﬁnd enough evidence to support a
causal association between maternal smoking during pregnancy and offspring autism or related traits.
Introduction
Autism spectrum disorders (ASDs) are complex neu-
rodevelopmental disorders characterised by persistent
deﬁcits in social communication and social interactions
and by restricted, repetitive patterns of behaviours,
interests or activities. There is increasing evidence to
suggest that environmental factors around birth may play
a role in the aetiology of ASD. Maternal smoking during
pregnancy has been implicated in the aetiology of autism1.
An increasing body of literature has reported a range of
adverse neuro-behavioural outcomes consequent to
maternal smoking including the risk of other neurode-
velopmental disorders, particularly externalising problems
such as attention-deﬁcit hyperactivity disorder
(ADHD)2,3. Smoking during pregnancy is also known to
be associated with neonatal complications that could be
on the causal pathway to later neurodevelopmental pro-
blems1. Prenatal exposure to smoking also leads to epi-
genetic modiﬁcations that are apparent in blood and that
persist throughout childhood and adolescence and might
impair neurodevelopment4. Several population-based
studies investigating the association between maternal
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smoking during pregnancy and offspring ASD have
returned inconsistent results1,5–15 and meta-analyses of
these studies did not support an association16–18. How-
ever, a recent meta-analysis suggests that taking other
factors into account such as paternal smoking and
second-hand smoking could account for the heterogeneity
between the different studies19. Altogether these studies
remain inconclusive.
One possible reason behind the inconsistent ﬁndings is
that smoking in pregnancy is not uniformly distributed in
the population and is highly socially patterned. Conse-
quently, any observed associations could be confounded
by socioeconomic factors11. However, despite attenuation
of associations in some studies6,11, others reported ‘posi-
tive’ associations of maternal smoking with ASD, which
persisted after adjustment for socioeconomic factors8,13,14,
and some studies did not ﬁnd any primary associa-
tion5,6,9,12. Even after adjusting for measured variables,
residual or unmeasured confounding is a potentially
important issue in observational studies20. Unmeasured
confounders could potentially include maternal factors
that relate to their mood or stress levels during pregnancy,
as these have been linked with both smoking behaviour
and ASD21,22. However, previous studies that found an
effect of maternal smoking on ASD did not adjust speci-
ﬁcally for mood disorders during pregnancy.
Among various approaches to address confounding,
Mendelian randomisation (MR) has been used to inves-
tigate causality where observational associations have
been previously found. In a MR framework, a genetic
variant is used as a proxy for the exposure of interest and,
since genetic variants are randomly allocated at concep-
tion, they are not liable to confounding23. Previous large-
scale genetic population studies have identiﬁed genetic
variants that are strongly associated with smoking beha-
viour. The single-nucleotide polymorphism (SNP)
rs1051730:G > A in the CHRNA5-CHRNA3-CHRNAB4
gene cluster coding for nicotinic receptor subunit pro-
teins24,25 is strongly associated with heaviness of smoking
in smokers (i.e. number of cigarettes smoked per day).
MR studies using this gene variant for smoking during
pregnancy have added evidence to determine whether it
has consequences for prenatal depression and birth
weight26–28.
It has also been suggested that smoking is often mis-
reported, especially during pregnancy, where the beha-
viour is considered socially undesirable29. Biomarkers may
be preferable to provide a more objective measure of
smoking exposure, and recent epigenetic scores derived
from DNA methylation data have been proposed to be
used in place of self-reported smoking behaviour30.
Another way to determine whether maternal smoking
exposure has a causal effect on risk of ASD is to include a
negative control exposure in the analysis31. Partner’s
smoking during pregnancy is as socially patterned as
maternal smoking therefore its inﬂuence on the child’s
neurodevelopment may arise from sharing the same
socioeconomic confounders with maternal smoking.
However, maternal smoking can affect the risk of devel-
oping ASD directly via intrauterine mechanisms, assum-
ing the effects of passive smoking from exposure to
partner smoking are minimal. For instance, cotinine levels
in pregnant women were found to be mostly associated
with their own smoking status, rather than with their
partner’s32. Partner’s smoking acts therefore as a negative
control for the main exposure and we would expect its
association with ASD to be weaker than that of maternal
smoking with ASD if in utero smoke exposure was causal.
Furthermore, there is evidence to suggest that impair-
ments in various domains used to describe ASD may have
varying aetiologies33. Studies investigating component
traits of ASD may therefore be useful in the identiﬁcation
of ASD risk factors as maternal smoking might be dif-
ferentially harmful for the different symptoms of ASD.
ASD-related traits can also present in children without
ASD diagnosis and therefore population-based studies
that consider autistic traits are informative as the cut-off
for diagnosis is often arbitrary and almost all traits occur
in a continuum of severity34.
In this study we investigated the causal effect of
maternal smoking during pregnancy on children’s ASD
and ASD traits using three approaches. First, we used the
traditional observational analysis (self-reported smoking
and epigenetic score) adjusted for potential confounders.
We then investigated the effect of partner’s smoking as a
negative control. Finally, we performed exploratory MR
using a maternal genetic variant as proxy for smoking
heaviness.
Materials and methods
Study population
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a birth cohort based in Avon, UK35,36. Data
were collected via self-completed questionnaires admi-
nistered to the mothers at four time points during preg-
nancy, to the partners at two time points during
pregnancy and to the mothers and their partners (mainly
fathers) at regular intervals following birth. Since the age
of 7 years the children were also administered ques-
tionnaires. Ethical approval for this study was obtained
from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees.
The study website contains details of all the data that
are available through a fully searchable data dictionary:
http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary.
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Exposure: prenatal smoking
Maternal smoking status during pregnancy was
obtained from the questionnaires administered to the
mothers at 8, 18–32 weeks of gestation and just after
birth. These data were combined into a dichotomous
variable for any reported smoking vs. none.
Maternal smoking was also assessed using a smoking
epigenetic score that was created for each of the ALSPAC
mother–child pair with DNA methylation measured as
part of the Accessible Resource for Integrated Epigenomic
Studies37. Details of data generation can be found in the
Supplementary Material. From the beta values of mother’s
DNA methylation data collected antenatally, methylation
scores were calculated using three different methods: (i)
the Elliott score was calculated using the procedure
reported in Elliott et al.30, with summary statistics taken
from Zeilinger et al.38; (ii) the Joehanes score was calcu-
lated as a weighted additive score using the 2622 sites at p
< 10−8 from Supplementary Table 2 in Joehanes et al.39;
(iii) the Joehanes-PC-adjusted score was calculated as the
Joehanes score except the beta values were adjusted for 10
principal components that derived from the most variable
10,000 CpG sites prior to the score calculation. From the
beta values of cord blood methylation, two methylation
scores were computed: (i) the Joubert score was calculated
using as a weighted additive score using 568 sites from
Supplementary Table 3 in Joubert et al.40; (ii) the Joubert-
PC-adjusted score was calculated as the Joubert score
except the beta values were adjusted for 10 principal
components that derived from the most variable 10,000
CpG sites prior to score calculation. The ﬁve scores
generated were then compared in terms of predicting
pregnancy smoking and the best predictor based on the
pseudo-R2 was chosen for the main analysis.
Partner’s smoking status during pregnancy was
obtained from questionnaires administered to the
mothers at 18 weeks of gestation regarding their partners’
current smoking status and to the partners asking about
their own smoking habits during the pregnancy period. A
categorical variable with current smokers vs. non-smokers
(either never smoked or stopped smoking) was created.
Outcome variables
Autism spectrum disorder
Children with ASD within ALSPAC were identiﬁed
using a multisource approach: (a) a review of all children
given a statement for special educational provision in the
Avon area to identify children with a diagnosis of ASD
concordant with the International Classiﬁcation of Dis-
ease (10th Edition) (ICD-10) criteria41; (b) the mother’s
answer to the(question “Have you ever been told that your
child has autism, Asperger’s syndrome or ASD?” when the
child was 9 years old; (c) classiﬁcation by the educational
system as requiring special needs because of an ASD by
age 16; (d) text responses to any questions on child’s
diagnoses in questionnaires administered when the child
was between 6 months and 11 years; and (e) ad hoc letters
from parents to the Study Director42. Using these sources,
212 offsprings with reported or possible ASD diagnosis
were identiﬁed and 174 of these had information collected
prospectively during pregnancy. This method for deﬁning
ASD cases in ALSPAC has been previously validated42.
ASD-related traits
ASD traits used as outcomes in this study were four
measures derived from parental questionnaires in
ALSPAC, which were previously reported to optimally
predict ICD-10 ASD diagnosis out of 93 measures related
to autistic features collected in ALSPAC by age 11 years43:
(1) a social communication impairment score derived by
administering the Social and Communication Disorders
Checklist (SCDC) questionnaire to the mothers when the
children were 7.5 years of age44; (2) the Coherence sub-
scale of the Children’s Communication Checklist (CCC)
that was administered at 9.5 years of age45 as a measure of
pragmatic language skills; (3) a Repetitive Behaviour score
was derived from the answer to four questions sent to the
mothers at 69 months regarding how often the child
repeatedly rocks the head or body for no reason has a tic
or a twitch, has other unusual behaviour and whether they
stumble, get stuck on words or repeat them many times46;
and (4) the sociability subscale of the Emotionality
Activity and Sociability (EAS) temperament scale, which
measured at 38 months to assess the tendency to afﬁliate
and interact with others47. Since three of the scores
considered were highly skewed we dichotomised all the
scores into low- and high-risk groups. The SCDC was
dichotomised using a cut-off of ≥9 for the high-risk group
as this threshold was previously validated48. For pragmatic
language ability coherence and EAS sociability, we
reverted the scale and created a high-risk group for ASD
of as close to 10% of the population as possible. For
repetitive behaviour we also created a high-risk group for
ASD of as close to 10% of the population as possible. We
also used the previously published ASD factor mean score
from a factor analysis of all the 93 traits that were
potentially related to ASD as an outcome representing the
broad autism phenotype43.
Covariates
A number of variables considered potential confounders
were included in the adjusted analyses. These were off-
spring sex and several maternal variables: age, parity,
education, social class, ﬁnancial difﬁculties and antenatal
depression. Maternal age was derived from the date of
birth that was recorded in a questionnaire administered at
8 weeks. Parity (number of previous pregnancies resulting
in live births or stillbirths) was recorded in a
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questionnaire administered to the mother at 18 weeks of
pregnancy and was dichotomised into ‘no previous chil-
dren’ and ‘at least one child’. For maternal education the
highest education level reached was reported in a ques-
tionnaire at 32 weeks of pregnancy and was dichotomised
into possessing a University degree or not. Occupational
class was derived from the maternal occupation stated in
questionnaires administered at 32 weeks of pregnancy and
collapsed into two categories representing ‘manual occu-
pations’ and ‘non-manual occupations’ (according to the
1991 British Ofﬁce of Population Census Surveys job
codes). Financial difﬁculties were recorded as having dif-
ﬁculties affording things for the baby, accommodation,
heating, clothing and food and combined into a score
(0–15). The score was dichotomised with a cut-off of ≥9
representing the 10% of the sample with high ﬁnancial
difﬁculties. Maternal depression was ascertained using the
Edinburgh Postnatal Depression Scale measured at
18 weeks of pregnancy, which is a score ranging from 0 to
30 with higher scores indicating more severe depressive
symptoms49.
Genetic variants for MR
Within a MR framework, the number of alleles at
common genetic variants that are robustly associated with
smoking behaviour is used as the exposure variable
instead of the exposure of interest, smoking behaviour.
Evidence of an association between the genetic variants
for smoking in the study mothers and children’s ASD or
autism-related traits would indicate a causal link. The
SNP rs1051730:G > A within the CHRNA3 locus was
chosen to proxy for exposure to tobacco smoke in the MR
study because of its strong association with heaviness of
smoking, rather than smoking initiation or cessation,
which might be more prone to socioeconomic patterns.
Maternal genotype (number of alleles) at rs1051730:G > A
was extracted from the ALSPAC genetic database, which
contains genome-wide data on ALSPAC mothers and
children35. Details of generation of the genetic data are
provided in the Supplemental Methods.
Statistical analysis
The association between maternal smoking and ASD/
autistic traits was assessed using logistic regression
models with self-reported smoking and epigenetic
smoking score as exposure variables and with ASD diag-
nosis or individual ASD traits as outcome variables. Lin-
ear regression models were run when the ASD factor
mean score was used as outcome. Partner’s smoking was
used as a negative control exposure variable and its
association with child ASD and autistic traits was esti-
mated. First, we estimated associations adjusted for sex of
the child. In the fully adjusted model we adjusted for sex,
maternal age at delivery, parity, maternal education, social
class and ﬁnancial difﬁculties as potential confounders.
We also ran a separate model that included both maternal
and partner’s smoking together as a means of mutual
adjustment. Both the maternal and partner’s smoking
analyses were further adjusted for mother depression
symptoms to rule out confounding by maternal
depression.
MR analysis was carried out by assessing the effect of
smoking-associated maternal genotype at the CHRNA3
locus (rs1051730:G > A) on ASD and autistic traits. First,
the association between maternal genotype and heaviness
of smoking was conﬁrmed in the study sample using
linear regression with the number of A alleles (0, 1 and 2)
for each genotype as the exposure variable and heaviness
of smoking during pregnancy (number of cigarettes
per day) as outcome within each trimester. We performed
this analysis by trimester because heaviness of smoking
varied in each trimester. Then, the effect of maternal
genotype on ASD and autistic traits was assessed in
logistic regression models for each SNP with number of A
alleles at rs1051730:G > A as exposure and ASD or autistic
traits as binary outcomes. Linear regression was used
when the factor mean score for ASD was the outcome.
The MR analysis was carried out stratiﬁed by smoking
during pregnancy since the genetic variant is an instru-
ment for heaviness of smoking within smokers and across
the whole pregnancy rather than by trimester as the
outcome sample size would be considerably reduced.
The power analysis estimated that based on our samples
sizes and on the summary statistics of the control groups
in our study we had, at alpha= 0.05, 80% power to detect:
in the observational analysis of maternal smoking and
paternal smoking an odds ratio of at least 1.63 for ASD
diagnosis and at least 1.2–1.3 for the ASD-related traits;
for smoking methylation score an odds ratio of at least
1.45 for ASD diagnosis and at least 1.07 for ASD-related
traits; for number of smoking alleles an odds ratio of at
least 2.45 for ASD diagnosis and at least 1.45 for ASD-
related traits.
All the analyses were performed using STATA 15.0
(StataCorp LLC, Texas, USA) and R 3.3.3 (https://www.r-
project.org/).
Results
The baseline characteristics of the study populations are
reported in Table 1 and show consistency across the
samples for the three different exposures considered
(maternal smoking during pregnancy, maternal genotype
and partner’s smoking during pregnancy).
The association of potential confounding factors with
mothers’ and partner’s smoking status during pregnancy
is shown in Supplemental Table S1. Compared to mothers
who did not smoke during pregnancy, mothers who did
smoke had more boys, were on average 3 years younger,
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more often employed in manual jobs, had lower educa-
tion, reported more ﬁnancial difﬁculties and had higher
depression scores. Similar associations were seen with
partner’s smoking status during pregnancy.
In sex-adjusted models maternal smoking was asso-
ciated with higher risk of social communication impair-
ment SCDC score, increased repetitive behaviour and an
increased ASD risk predicted by the factor mean score.
There was an apparent protective association with ASD
diagnosis (Table 2). There was strong evidence of con-
founding and these associations shifted towards the null
upon adjustment with socioeconomic covariates, partner’s
smoking and maternal depression.
The same analyses conducted by pregnancy trimester
showed similar results, with the strongest associations in
the second trimester (Supplemental Tables S2, S3 and S4).
Partner’s smoking associations in sex-adjusted models
mirrored those of the mother, except for repetitive
behaviour where the association was weaker. There was
evidence for confounding. When adjusting for maternal
smoking and depression, the association with SCDC score
remained, whereas the association with ASD factor mean
score was shifted towards the null (Table 3). The pro-
tective effect on ASD diagnosis was also weaker after
adjusting for socioeconomic covariates and maternal
depression.
Among the ﬁve different smoking methylation scores,
the Elliott score was explaining 58% of the variance in
maternal pregnancy smoking and was taken forward in
the analysis (Supplemental Table S5). Using this score, the
average smoking methylation score difference between
non-smokers and smokers was 9.85 points [95% con-
ﬁdence interval= 9.21–10.49] (n= 886, p < 0.0005). The
methylation score was able to separate smokers and non-
smokers according to a threshold of 5.44 points at 73%
sensitivity and 96% speciﬁcity (Supplemental Figure S1).
Due to the reduced sample size in the methylation sub-
sample, the analysis on diagnosed ASD was only carried
out without adding any covariates to the model. There
was no evidence of an association between methylation
score and ASD or autistic traits (Table 4).
The number of A alleles at the SNP rs1051730:G > A in
the CHRNA3 locus was associated with heaviness of
smoking during pregnancy (Supplementary Table S6) at
all three trimesters. The effect was more pronounced in
the ﬁrst trimester with each additional A alleles being
associated with 1 more cigarette per day on average.
Genetic variation at rs1051730:G > A was not associated
with any of the potential confounders (Supplemental
Table S7). In pregnancy smokers, genetic variation at the
CHRNA3 locus was not associated with any ASD or ASD-
related traits, whereas in pregnancy non-smokers each
Table 1 Baseline characteristics of the study populations in the ALSPAC sub-samples with data on maternal smoking,
partner smoking and with genotype data
Variable Maternal smoking sample
(N ≤ 12,044)a
Partner smoking sample
(N ≤ 11,116)a
Maternal genotype sample
(N ≤ 8771)a
Sex (%male) 51.83 51.54 50.20
ASD (%cases) 1.24 1.18 1.14
SCDC (%high score) 7.88 7.56 7.70
CCC coherence (%low score) 10.34 9.79 9.72
Repetitive behaviour (%high score) 6.95 7.03 6.75
EAS sociability (%low score) 11.59 11.34 11.43
Maternal education (university degree) 13.19 13.51 13.80
Social class (%manual) 19.50 19.38 18.04
Parity (%multiparous) 56.21 54.43 54.08
Mothers smoking (%) 30.68 30.15 27.45
Partners smoking (%) 42.51 43.39 40.64
Financial difﬁculties (%) 9.93 9.26 8.95
Maternal age, mean (sd) 28.22 (4.89) 28.15 (4.88) 28.34 (4.76)
EPDS score, mean (sd) 6.92 (4.85) 6.89 (4.82) 6.75 (4.75)
ASD autism spectrum disorder, SCDC Social and Communication Disorders Checklist, CCC Children’s Communication Checklist, EAS Emotionality Activity and
Sociability, EPDS Edinburgh Postnatal Depression Scale
aN varies according to completeness of data on baseline characteristics
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additional A allele was associated with improved CCC
speech coherence score (Table 5).
Discussion
In this population-based birth cohort study with pro-
spectively collected data, we used a number of analytic
strategies to study the association between maternal
smoking in pregnancy and autism-related outcomes. We
observed some initial evidence of an association between
exposure to maternal smoking on behavioural traits
linked with ASD, which was attenuated after accounting
for potential confounding factors. We found that partner’s
smoking is also associated with autistic traits in a similar
way to maternal smoking further suggesting that the
association is unlikely to be due to an intrauterine effect
but that it is more likely to reﬂect shared confounding.
Our analyses using an epigenetic score to reduce the
likelihood of reporting bias for maternal smoking status
and using a genetic proxy for smoking heaviness in a MR
framework also did not support the possibility of a causal
association, although both these analyses had lower power
to detect an effect.
Our results are in line with the most recent meta-
analysis based on 22 studies where the evidence on the
association between maternal smoking and ASD has been
reviewed and the pooled estimate shows a null associa-
tion19. The studies included in this meta-analysis are very
heterogeneous and location of the study, study design,
sample size and maternal smoking assessment seem to
moderate the association. Particularly, positive associa-
tions are more likely to be found in locations outside of
Europe and the United States, studies of smaller sample
sizes, lower quality, with a case-control design, postnatal
assessment of maternal smoking, lack of adjustment for
potential confounders and parental reports of ASD diag-
nosis. These studies might have suffered from selection
bias due to small selected samples, recall bias due to
postnatal ascertainment and confounding bias. In com-
parison, our study has strengths in all these areas.
Moreover, our study adds to the meta-analysis by showing
the absence of evidence for an association with symptoms
of autism as measured by the ASD traits.
Interestingly, the estimates from the models not adjus-
ted for socioeconomic confounders showed an effect of
Table 2 Association of maternal smoking during pregnancy with child’s autism spectrum disorder and ASD traits
without adjustment and with adjustment for socioeconomic status, partner’s smoking and maternal depression
Outcome Model 1 Model 2 Model 3 Model 4
N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value
ASD 11,946 0.66
[0.45, 0.97]
0.033 8986 0.67
[0.40, 1.12]
0.124 7684 0.83
[0.46, 1.50]
0.543 7274 0.84
[0.46, 1.56]
0.208
SCDC score 7402 1.56
[1.29, 1.87]
<0.0005 6142 1.52
[1.22, 1.89]
<0.0005 5380 1.31
[1.02, 1.70]
0.038 5135 1.23
[0.94, 1.60]
0.130
CCC coherence
(reverted)
7096 1.19
[0.99, 1.42]
0.063 5899 1.08
[0.87, 1.34]
0.481 5182 1.13
[0.88, 1.46]
0.326 4952 1.04
[0.80, 1.34]
0.780
Repetitive
behaviour
7854 1.34
[1.09, 1.61]
0.004 6474 1.28
[1.01, 1.62]
0.043 5665 1.21
[0.93, 1.59]
0.161 5415 1.09
[0.82, 1.44]
0.549
EAS sociability
(reverted)
9152 0.99
[0.85, 1.15]
0.891 7392 0.85
[0.71, 1.02]
0.089 6421 0.84
[0.67, 1.03]
0.097 6119 0.80
[0.64, 1.00]
0.051
N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value
ASD
mean
factor score
(standardised)
11,317 −0.11
[−0.15, −0.07]
<0.0005 8744 −0.04
[−0.09, 0.01]
0.092 7500 −0.04
[−0.10, 0.01]
0.143 7114 0.00
[−0.06, 0.06]
0.963
ASD autism spectrum disorder, SCDC Social and Communication Disorders Checklist, CCC Children’s Communication Checklist, EAS Emotionality Activity and Sociability
Model 1= adjusted for sex of the child
Model 2= adjusted for sex of the child, maternal age, parity, maternal education, social class and ﬁnancial difﬁculties
Model 3= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and partner’s smoking
Model 4= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and partner’s smoking and maternal depression
Crude model (no sex adjustment)
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maternal smoking in opposite directions, with a reduction
in risk of ASD diagnosis and an increase in risk of ASD-
related traits. However, the evidence for the reduction in
ASD is not strong when considering the number of tests
conducted (Bonferroni p-value threshold is 0.008 per
model tested and six outcomes). If this is a true ﬁnding, it
might be the reﬂection of the different socioeconomic
patterning of ASD diagnosis and ASD-related traits, with
children of higher income families being diagnosed for
ASD more often than lower income ones50 and children
with non-clinical autistic traits in the general population
coming from low-income families more than higher-
income ones51. Since maternal smoking is associated with
ASD and autistic traits in opposite directions, this
strengthens the idea that maternal smoking is a reﬂection
of socioeconomic status rather than a causal intrauterine
factor for autism.
The main strength of our study is the integration of
evidence from several different epidemiological approa-
ches that have differing and unrelated sources of bias, to
understand if maternal smoking during pregnancy confers
a higher risk of developing ASD or ASD-related traits52.
Our study strengthens the hypothesis of no association by
using multivariable regression analysis (where maternal
smoking is both self-reported and measured using an
epigenetic biomarker), partner’s smoking as a negative
control and a MR approach. Other studies have reported a
positive association between maternal smoking and chil-
dren’s behavioural difﬁculties or neurodevelopment in
general (reviewed in ref. 53), which seems to support the
association reported here in sex-adjusted models on social
communication and repetitive behaviours. It has been
suggested that the associations found in previous studies
are due to unmeasured confounding. In our study we
further adjusted for several socioeconomic confounders to
reduce this bias and the concordance between the
mother’s and partner’s effect estimates leads to shared
unmeasured confounding as the most plausible explana-
tion. A similar pattern of matching maternal and paternal
effects of smoking on children’s neuro-behavioural out-
comes was observed previously on ADHD54, suggesting a
more general confounding structure that includes other
behavioural issues. Although adjusting for partner’s
smoking might not provide a point estimate of the causal
effect of maternal smoking in the presence of differential
measurement error such as reporting bias55, when com-
pared with the other approaches the results weaken the
hypothesis of a direct intrauterine effect of maternal
smoking. Further adjustment for maternal depression
additionally attenuated the estimates. This might be due
Table 3 Association of partner smoking during pregnancy with child’s autistic spectrum disorder and ASD traits in
models without adjustment and with adjustment for socioeconomic status, maternal smoking and maternal depression
Outcome Model 1 Model 2 Model 3 Model 4
N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value
ASD 10,995 0.51
[0.35, 0.75]
0.001 8307 0.56
[0.35, 0.89]
0.014 7684 0.58
[0.35, 0.96]
0.035 7274 0.60
[0.36, 1.02]
0.057
SCDC score 6879 1.56
[1.30, 1.87]
<0.0005 5784 1.39
[1.13, 1.71]
<0.002 5380 1.32
[1.05, 1.67]
0.018 5135 1.34
[1.06, 1.70]
0.014
CCC coherence
(reverted)
6616 1.05
[0.89, 1.24]
0.573 5582 0.99
[0.82, 1.20]
0.926 5182 0.93
[0.74, 1.15]
0.484 4952 0.91
[0.73,1.14]
0.416
Repetitive behaviour 7284 1.11
[0.92, 1.33]
0.270 6087 1.08
[0.87, 1.33]
0.504 5665 1.05
[0.83, 1.34]
0.686 5415 1.05
[0.82, 1.34]
0.720
EAS sociability
(reverted)
8421 1.10
[0.96, 1.26]
0.174 6920 1.02
[0.87, 1.20]
0.835 6421 1.09
[0.91, 1.31]
0.333 6119 1.08
[0.90, 1.30]
0.397
N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value N Beta
[95% CI]
p-Value
ASD
mean factor score
(standardised)
10,315 −0.09
[−0.13, −0.5]
<0.0005 8098 −0.03
[−0.08, 0.01]
0.126 7500 −0.02
[−0.06, 0.03]
0.526 7114 −0.01
[−0.06, 0.04]
0.769
ASD autism spectrum disorder, SCDC Social and Communication Disorders Checklist, CCC Children’s Communication Checklist, EAS Emotionality Activity and Sociability
Model 1= adjusted for sex of the child
Model 2= adjusted for sex of the child, maternal age, parity, maternal education, social class and ﬁnancial difﬁculties
Model 3= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and maternal smoking
Model 4= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and maternal smoking and maternal depression
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to women with depression being more likely to smoke
during pregnancy as smoking rates are higher in persons
with mental illness56 and to an association of depression
in pregnancy with ASD which has been previously
reported21,22.
The MR analysis minimises the possibility of con-
founding due to the randomisation of the alleles at con-
ception. Such analysis is possible on cohorts like the
ALSPAC where the maternal genotype across the genome
has been measured. Smoking behaviour can be instru-
mented because the genotype at rs1051730:G > A within
the CHRNA3 gene is strongly associated with smoking
heaviness25,57–59 and the association has been replicated
in this study. The only association between this genetic
variant and the autistic-related outcomes in this study is
within the pregnancy non-smokers, where an effect of
Table 4 Association of maternal smoking during pregnancy as estimated by epigenetic score with child’s autism
spectrum disorder and ASD traits in models without adjustment and with adjustment for socioeconomic status, partner’s
smoking and maternal depression
Outcome Model 1 Model 2 Model 3 Model 4
N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value N OR
[95% CI]
p-Value
Any ASDa 964 1.07
[0.96, 1.18]
0.245 – – – – – – – –
SCDC score 877 1.03
[0.98, 1.09]
0.191 763 1.00
[0.94, 1.06]
0.961 653 1.00
[0.93, 1.08]
0.966 640 1.00
[0.93, 1.07]
0.901
CCC coherence (reverted) 879 1.00
[0.95, 1.05]
0.993 766 0.98
[0.93, 1.04]
0.586 656 0.97
[0.91, 1.04]
0.456 644 0.97
[0.90, 1.03]
0.360
Repetitive behaviour 866 0.95
[0.89, 1.01]
0.095 763 0.96
[0.89, 1.03]
0.269 648 0.96
[0.89, 1.04]
0.372 636 0.97
[0.88, 1.04]
0.348
EAS sociability (reverted) 898 0.99
[0.94, 1.04]
0.574 791 0.97
[0.92, 1.03]
0.325 676 0.96
[0.90, 1.03]
0.295 664 0.96
[0.90, 1.03]
0.226
ASD
mean factor score
(standardised)
963 0.00
[−0.01, 0.01]
0.964 832 0.01
[−0.01, 0.02]
0.371 705 0.01
[0.00, 0.02]
0.145 691 0.01
[0.00, 0.02]
0.100
ASD autism spectrum disorder, SCDC Social and Communication Disorders Checklist, CCC Children’s Communication Checklist, EAS Emotionality Activity and Sociability
Model 1= adjusted for sex of the child
Model 2= adjusted for sex of the child, maternal age, parity, maternal education, social class and ﬁnancial difﬁculties
Model 3= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and partner’s smoking
Model 4= adjusted for sex of the child, maternal age, parity, maternal education, social class, ﬁnancial difﬁculties and partner’s smoking and maternal depression
aCrude model (no sex adjustment)
Table 5 Effect of additional A alleles at rs1051730 on child’s autism spectrum disorder and ASD traits
Pregnancy smokers Pregnancy non-smokers
Outcome N OR [95% CI] p-Value N OR [95% CI] p-Value
Any ASD 2037 0.79 [0.40, 1.56] 0.504 5399 1.09 [0.77, 1.53] 0.628
SCDC score 1085 0.89 [0.66, 1.20] 0.446 3911 0.95 [0.78, 1.15] 0.575
CCC coherence (reverted) 1002 0.87 [0.64, 1.18] 0.373 3923 0.80 [0.68, 0.95] 0.010
Repetitive behaviour 1197 0.81 [0.59, 1.11] 0.197 4152 0.90 [0.74, 1.09] 0.277
EAS sociability (reverted) 1417 1.07 [0.84, 1.37] 0.572 4659 1.04 [0.91, 1.19] 0.563
N Beta [95% CI] p-Value N Beta [95% CI] p-Value
ASD factor mean score
(standardised)
1876 0.03 [−0.03, 0.10] 0.345 5316 0.00 [−0.04, 0.04] 0.998
ASD autism spectrum disorder, SCDC Social and Communication Disorders Checklist, CCC Children’s Communication Checklist, EAS Emotionality Activity and Sociability
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smoking heaviness is not expected. The evidence for this
association is weak considering the number of tests car-
ried out (above the Bonferroni p-value threshold for six
outcomes investigated of 0.05/6= 0.008). If this effect is
true, this could be due to pleiotropy, i.e. the genetic var-
iant affecting the outcome via pathways other than
smoking. A look-up analysis performed on MR-Base
(www.mrbase.org; last access on 07/02/2018) found an
association of rs1051730:G > A with several smoking
variables and with schizophrenia at Bonferroni-corrected
threshold p-value= 3.08 × 10−5 (Supplementary Table
S8). The pragmatic language coherence score that we
identiﬁed being affected by this genetic variant in non-
smokers could therefore be the result of a direct effect of
maternal CHRNA3 on language development bypassing
smoking, for example, via the mother’s own language
development.
Another advantage of using a prospective cohort is that
it minimises the possibility of recall bias since all the
parents were asked about their smoking habits during
pregnancy. To further reduce measurement bias we uti-
lised an epigenetic score calculated from the maternal
blood DNA methylation proﬁles. The score did not give a
perfect distinction between smokers and non-smokers
either due to reporting bias from self-report or mea-
surement error and it added an extra approach to examine
the association of smoking behaviour during pregnancy
on neurodevelopment. In this analysis, the fact that we did
not ﬁnd the same associations of maternal smoking with
social communication and repetitive behaviour could be
due to the relatively small sample size, which did not
allow as much power as for the main analysis.
The main limitation of this study is the low number of
ASD cases in the study population and the small sample
size in the genetic and epigenetic analysis, which may
have compromised the statistical power for comparisons.
Moreover, since ASD ascertainment included reported or
possible ASD diagnosis, ASD cases are likely to include
false positives. However, the results are consistent across
the different analyses suggesting that a causative link
between maternal smoking during pregnancy and autistic
features is unlikely.
In conclusion, taken together our study did not ﬁnd
evidence to support a causal association between maternal
smoking during pregnancy and ASD or autistic-like
behaviours via intrauterine mechanisms.
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